Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment
about
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expressionN-acetylcysteine -- passe-partout or much ado about nothing?Inflammatory and oxidative stress in rotavirus infectionModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsIn vitro effect of bioactive compounds on influenza virus specific B- and T-cell responsesN-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infectionSynergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse modelN-acetylcysteine lacks universal inhibitory activity against influenza A viruses.Rhinovirus-induced barrier dysfunction in polarized airway epithelial cells is mediated by NADPH oxidase 1.Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.Effects of (L)-cystine and (L)-theanine supplementation on the common cold: a randomized, double-blind, and placebo-controlled trial.Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its PreventionTOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary FibrosisThe role for N-acetylcysteine in the management of COPDRole of mucolytics in the management of COPD.An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderlyInhibition of rotavirus ECwt infection in ICR suckling mice by N-acetylcysteine, peroxisome proliferator-activated receptor gamma agonists and cyclooxygenase-2 inhibitors.Anti-inflammatory mediators as physiological and pharmacological regulators of parturition.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Antiviral strategies against influenza virus: towards new therapeutic approaches.The role of cellular oxidoreductases in viral entry and virus infection-associated oxidative stress: potential therapeutic applications.Oxidation pathway and exacerbations in COPD: the role of NAC.Successful treatment of non-healing pressure ulcers with topical n-acetyl cysteine.N-Acetylcysteine treatment of rotavirus-associated diarrhea in children.Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health.Ameliorative effect of N-acetyl cysteine on alpha-cypermethrin-induced pulmonary toxicity in male rats.Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology.Redox Biology of Respiratory Viral Infections
P2860
Q21135459-A6C17875-AB55-49F7-8CE8-AF97128E6E8DQ24678741-46C618E4-D327-4E0F-9B98-9F5FEFB82985Q26749801-A5D9EBEA-87DA-439E-9403-7A94C1612147Q26800158-0FC352DC-034C-4F75-B73A-D610A88EE965Q28200930-D2C17633-095F-449D-A117-69EE52EC0C7FQ28236065-1CFA318C-389E-4BD7-823F-F33653442CADQ28248363-407A75AD-B65E-443E-9F8D-4B971FE49D75Q35014574-D363EED8-6122-4992-AB1C-B4FC232F33D2Q35077536-F76C7FA8-8BE6-441D-9508-90B36BE0FCA7Q35627625-0048F5E5-D4FA-4E7E-880F-C22798D9B2FFQ35746330-7976C990-CF59-4950-B532-0795574D51E7Q35788081-1FE1452B-D70F-4CAA-B098-CBD4B3355EC0Q36516894-7205D806-5BBD-4CB1-82A1-1E60B43CA5CCQ37018878-D7EF71B7-AE88-4D95-85F3-EFE1B2D56444Q37018892-BF9CD7B8-3455-441C-AB9B-EB5C94CB81CEQ37219282-E0F4F844-942B-446A-923A-BFCAFFD4ACDBQ37675315-21FA9D05-627C-40A7-ABA3-520BF4EA6CABQ37927081-72347E95-7409-4AF6-934B-DFC9C637B7C9Q38182646-4B96082C-7C9E-4AA5-82D1-4069553EA803Q38202012-C2765445-B289-4727-AA07-DF9417F817FCQ38547857-27E7FC87-5A05-4DF0-BC26-6A76FCE42556Q38633304-C4E030E0-D2C0-46B4-A132-907BC180D4C9Q40225150-AD36FDA9-6B5C-49F4-929D-15737F864273Q41727879-CC0AA16F-8149-4342-98BE-A217B932C37CQ42338456-4A3C5819-31EE-48F5-AA6B-F182EB35C3B9Q42710051-543936A0-1A20-436E-B733-411514C888BAQ45061570-1E6154F2-1A45-422A-A8BA-A1808137E4EBQ56967921-07E9FE35-EE70-4C7C-91CB-B4E45DBADDCF
P2860
Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@ast
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@en
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@nl
type
label
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@ast
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@en
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@nl
prefLabel
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@ast
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@en
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@nl
P2093
P1476
Attenuation of influenza-like ...... erm N-acetylcysteine treatment
@en
P2093
P304
P356
10.1183/09031936.97.10071535
P407
P577
1997-07-01T00:00:00Z